Explainer 62 - FDA's Regulation of Laboratory Developed Tests episode artwork

EPISODE · Feb 9, 2024 · 34 MIN

Explainer 62 - FDA's Regulation of Laboratory Developed Tests

from RTP's Fourth Branch Podcast · host The Federalist Society

For many years FDA has claimed the authority to regulate Laboratory Developed Tests, that is tests that are designed, produced, and used in a single lab – never being put up for sale. This authority, however, has been contested, and the FDA itself has traditionally practiced “discretionary enforcement,” wherein it has regulated LDTs very little. A change occurred in October 2023 when the FDA issued a notice of proposed rulemaking wherein it indicated its intention to codify its claim of authority and begin enforcing oversight of LDTs. Dr. Joel Zinberg, M.D., J.D., joined us to discuss the history the FDA’s regulation of LDTs, the proposed rule, and what the ramifications may be. Featuring: Dr. Joel Zinberg, Senior Fellow, Competitive Enterprise Institute

Episode metadata supplied by the publisher feed · Published Feb 9, 2024

Embed this episode

NOW PLAYING

Explainer 62 - FDA's Regulation of Laboratory Developed Tests

0:00 34:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RTP's Fourth Branch Podcast?

This episode is 34 minutes long.

When was this RTP's Fourth Branch Podcast episode published?

This episode was published on February 9, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this RTP's Fourth Branch Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!